全球空间基因组学和转录组学市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，空间基因组学和转录组学市场规模将达到 1,826,960,000 美元，高于 2025 年的 491,350,000 美元，预计从 2026 年到 2034 年的复合年增长率将达到 15.71%。

由于能够分析组织空间背景下的基因表现，全球空间基因组学和转录组学市场正迅速发展。这项技术正在变革生物医学研究，尤其是在肿瘤学、神经科学和免疫学领域。不断增长的研究经费和人们对精准医疗日益浓厚的兴趣，都推动了全球市场的强劲成长。

关键驱动因素包括定序技术的进步、影像技术的改进以及对细胞层面疾病理解的日益增长的需求。製药和生物技术公司正越来越多地采用空间分析工具进行药物发现和生物标记鑑定。人工智慧 (AI) 和数据分析的融合进一步提升了空间基因组分析的准确性和价值。

随着临床应用的不断拓展，该市场的未来前景依然十分光明。随着技术的成本效益提高和标准化程度的提升，其应用预计将从实验室扩展到临床诊断领域。未来十年，研究机构和生技公司之间持续的创新与合作有望加速市场成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球空间基因体学与转录组学市场：按空间转录组学技术划分

• 市场分析、洞察与预测
• 空间转录组学
• 免疫组织化学（IHC）
• 萤光原位杂合反应（FISH）
• 定序
• 原位采集
• In Silico构建
• 基于显微镜的RNA成像技术
• 体内转录组分析 (TIVA)
• 空间基因组分析
• 基于萤光的定序
• 萤光显微镜
• 其他技术

第五章：全球空间基因体学与转录组学市场：依产品划分

• 市场分析、洞察与预测
• 消耗品
• 装置
• 软体
• 影像工具
• 生物资讯学工具
• 储存和管理资料库

第六章：全球空间基因体学与转录组学市场：按应用划分

• 市场分析、洞察与预测
• 转化研究
• 药物发现与开发

第七章 全球空间基因体学与转录组学市场：依最终使用者划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 受託研究机构
• 学术研究机构

第八章：全球空间基因体学和转录组学市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Natera Inc
  • 10x Genomics
  • Dovetail Genomics
  • Illumina Inc
  • S2 Genomics Inc
  • NanoString Technologies Inc
  • Seven Bridges Genomics
  • Horizon Discovery Group Plc
  • Cartana AB
  • Readcoor Inc
  • Bio-Techne Corporation
  • Bio-Rad Laboratories Inc
  • Danahar Corporation
  • BioSpyder Technologies Inc
  • Lunaphore Technologies SA

The Spatial Genomics & Transcriptomics Market size is expected to reach USD 1826.96 Million in 2034 from USD 491.35 Million (2025) growing at a CAGR of 15.71% during 2026-2034.

The Global Spatial Genomics & Transcriptomics Market has gained rapid momentum due to its ability to analyze gene expression within the spatial context of tissues. This technology is transforming biomedical research, especially in oncology, neuroscience, and immunology. Increasing research funding and rising interest in precision medicine are contributing to strong market growth worldwide.

The key drivers include advancements in sequencing technologies, improved imaging techniques, and the growing need for better disease understanding at the cellular level. Pharmaceutical and biotechnology companies are increasingly adopting spatial analysis tools for drug discovery and biomarker identification. The integration of artificial intelligence and data analytics is further enhancing the accuracy and value of spatial genomic insights.

Future prospects for this market remain highly promising as clinical applications expand. As technology becomes more cost-effective and standardized, its adoption is expected to grow beyond research laboratories into clinical diagnostics. Continued innovation and collaboration between research institutions and biotech companies will likely accelerate market expansion over the next decade.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Spatial Transcriptomics Technique

• Spatial Transcriptomics
• Immunohistochemistry (IHC)
• Fluorescent In-situ Hybridization (FISH)
• Sequencing
• In-situ Capturing
• In-silico Construction
• Microscopy-based RNA Imaging Techniques
• Transcriptome In-vivo Analysis (TIVA)
• Spatial Genomics Analysis
• Fluorescence In-situ Sequencing
• Fluorescence Microscopy
• Other Techniques

By Product

• Consumables
• Instruments
• Software
• Imaging Tools
• Bioinformatics Tools
• Storage and Management Databases

By Application

• Translational Research
• Drug Discovery & Development

By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes

COMPANIES PROFILED

• Natera Inc, 10x Genomics, Dovetail Genomics, Illumina Inc, S2 Genomics Inc, NanoString Technologies Inc, Seven Bridges Genomics, Horizon Discovery Group plc, Cartana AB, Readcoor Inc, BioTechne Corporation, BioRad Laboratories Inc, Danahar Corporation, BioSpyder Technologies Inc, Lunaphore Technologies SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY SPATIAL TRANSCRIPTOMICS TECHNIQUE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Spatial Transcriptomics Technique
• 4.2. Spatial Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunohistochemistry (IHC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fluorescent In-situ Hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. In-situ Capturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. In-silico Construction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Microscopy-based RNA Imaging Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Transcriptome In-vivo Analysis (TIVA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Spatial Genomics Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Fluorescence In-situ Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Fluorescence Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.13. Other Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Imaging Tools Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinformatics Tools Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Storage and Management Databases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Translational Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Spatial Transcriptomics Technique
  • 8.2.2 By Product
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Spatial Transcriptomics Technique
  • 8.3.2 By Product
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Spatial Transcriptomics Technique
  • 8.4.2 By Product
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Spatial Transcriptomics Technique
  • 8.5.2 By Product
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Spatial Transcriptomics Technique
  • 8.6.2 By Product
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Natera Inc
  • 10.2.2 10x Genomics
  • 10.2.3 Dovetail Genomics
  • 10.2.4 Illumina Inc
  • 10.2.5 S2 Genomics Inc
  • 10.2.6 NanoString Technologies Inc
  • 10.2.7 Seven Bridges Genomics
  • 10.2.8 Horizon Discovery Group Plc
  • 10.2.9 Cartana AB
  • 10.2.10 Readcoor Inc
  • 10.2.11 Bio-Techne Corporation
  • 10.2.12 Bio-Rad Laboratories Inc
  • 10.2.13 Danahar Corporation
  • 10.2.14 BioSpyder Technologies Inc
  • 10.2.15 Lunaphore Technologies SA